Intracavitary chemotherapy (Gliadel®) and oral low-dose etoposide for recurrent anaplastic ependymoma

Oncology Reports

Volumn 19, Issue 5, 2008, Pages 1219-1223

  Sardi, Iacopo ^a   Sanzo, Massimiliano ^a   Giordano, Flavio ^a   Sandri, Alessandro ^b   Mussa, Federico ^a   Donati, Pier A ^a   Genitori, Lorenzo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

BCNU; Ependymoma; Etoposide; Intracavitary chemotherapy

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; ETOPOSIDE; GADOLINIUM; TEMOZOLOMIDE; VINCRISTINE; ANTINEOPLASTIC AGENT; BIOMATERIAL; DECANEDIOIC ACID 4,4' (1,3 PROPANEDIYLBIS(OXY))BIS(BENZOIC ACID) COPOLYMER; DECANEDIOIC ACID-4,4'-(1,3-PROPANEDIYLBIS(OXY))BIS(BENZOIC ACID) COPOLYMER; DECANOIC ACID DERIVATIVE; POLYESTER;

ANAPLASTIC BRAIN EPENDYMOMA; ARTICLE; BRACHYTHERAPY; BRAIN NECROSIS; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CASE REPORT; CHILD; COMBINATION CHEMOTHERAPY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EPENDYMOMA; FEMALE; HISTOPATHOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; LOW DRUG DOSE; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE; ADOLESCENT; BRAIN; METHODOLOGY; PATHOLOGY; RADIOTHERAPY; RECURRENT DISEASE;

ADOLESCENT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOCOMPATIBLE MATERIALS; BRAIN; BRAIN NEOPLASMS; CHILD; DECANOIC ACIDS; EPENDYMOMA; ETOPOSIDE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POLYESTERS; RADIOTHERAPY; RECURRENCE;

EID: 47549090096     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.5.1219     Document Type: Article

References (33)

1. Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P, Albright AL, Wisoff JH, Milstein JM, Allen JC, Finlay JL, et al: Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin Oncol 12: 1607-1615, 1994.
2. Oya N, Shibamoto Y, Nagata Y, Negoro Y and Hiraoka M: Postoperative radiotherapy for intracranial ependymoma: analysis of prognostic factors and patterns of failure. J Neurooncol 56: 87-94, 2002.
3. Horn B, Heideman R, Geyer R, Pollack I, Packer R, Goldwein J, Tomita T, Schomberg P, Ater J, Luchtman-Jones L, Rivlin K, Lamborn K, Prados M, Bollen A, Berger M, Dahl G, McNeil E, Patterson K, Shaw D, Kubalik M and Russo C: A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol 21: 203-211, 1999.
4. Massimino M, Gandola L, Giangaspero F, Sandri A, Valagussa P, Perilongo G, Garre ML, Ricardi U, Forni M, Genitori L, Scarzello G, Spreafico F, Barra S, Mascarin M, Pollo B, Gardiman M, Cama A, Navarria P, Brisigotti M, Collini P, Balter R, Fidani P, Stefanelli M, Burnelli R, Potepan P, Podda M, Sotti G and Madon E: AIEOP Pediatric Neuro-Oncology Group. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. Int J Radiat Oncol Biol Phys 58: 1336-1345, 2004.
5. Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC, Dunkel I, Diez B, Sposto R, Ji L, Asgharzadeh S, Hukin J, Belasco J, Dubowy R, Kellie S, Termuhlen A and Finlay J: Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Pediatr Blood Cancer 39: 34-40, 2007.
6. Merchant TE and Fouladi M: Ependymoma: new therapeutic approaches including radiation and chemotherapy. J Neurooncol 75: 287-299, 2005.
7. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G, et al: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 345: 1008-1012, 1995.
8. Westphal M, Ram Z, Riddle V, Hilt D and Bortey E: On behalf of the Executive Committee of the Gliadel Study Group. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) 148: 269-275, 2006.
9. Lawson HC, Sampath P, Bohan E, Park MC, Hussain N, Olivi A, Weingart J, Kleinberg L and Brem H: Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J Neurooncol 83: 61-70, 2007.
10. Sandri A, Massimino M, Mastrodicasa L, Sardi N, Bertin D, Basso ME, Todisco L, Paglino A, Perilongo G, Genitori L, Valentini L, Ricardi U, Gandola. L, Giangaspero F and Madon E: Treatment with oral etoposide for childhood recurrent ependymomas. J Pediatr Hematol Oncol 27: 486-490, 2005.
11. Nicholson HS, Krailo M, Ames MM, Seibel NL, Reid JM, Liu-Mares W, Vezina LG, Ettinger AG and Reaman GH: Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group. J Clin Oncol 16: 3037-3043, 1998.
12. Merchant TE, Haida T, Wang MH, Finlay JL and Leibel SA: Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. J Neurosurg 86: 943-949, 1997.
13. Sexauer CL, Khan A, Burger PC, Krischer JP, van Eys J, Vats T and Ragab AH: Cisplatin in recurrent pediatric brain tumors. A POG Phase II study. A Pediatric Oncology Group Study. Cancer 56: 1497-1501, 1985.
14. Walker RW and Allen JC: Cisplatin in the treatment of recurrent childhood primary brain tumors. J Clin Oncol 6: 62-66, 1988.
15. Friedman HS, Krischer JP, Burger P, Oakes WJ, Hockenberger B, Weiner MD, Falletta JM, Norris D, Ragab AH, Mahoney DH Jr, et al: Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. J Clin Oncol 10: 249-256, 1992.
16. Brandes AA, Cavallo G, Reni M, Tosoni A, Nicolardi L, Scopece L, Franceschi E, Sotti G, Talacchi A, Turazzi S and Ermani M: A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia. Cancer 104: 143-148, 2005.
17. Bertolone SJ, Baum ES, Krivit W and Hammond GD: A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Study Group. J Neurooncol 7: 5-11, 1989.
18. Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD and Hammond GD: Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial. Cancer 66: 2465-2469, 1990.
19. Needle MN, Goldwein JW, Grass J, Cnaan A, Bergman I, Molloy P, Sutton L, Zhao H, Garvin JH Jr and Phillips PC: Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 80: 341-347, 1997.
20. Grill J, Kalifa C, Doz F, Schoepfer C, Sainte-Rose C, Couanet D, Terrier-Lacombe MJ, Valteau-Couanct D and Hartmann O: A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study. Pediatr Neurosurg 25: 7-12, 1996.
21. Mason WP, Goldman S, Yates AJ, Boyett J, Li H and Finlay JL: Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma - a report of the Children's Cancer Group. J Neurooncol 37: 135-143, 1998.
22. Kalifa C, Valteau D, Pizer B, Vassal G, Grill J and Hartmann O: High-dose chemotherapy in childhood brain tumours. Childs Nerv Syst 15: 498-505, 1999.
23. Robertson PL, Zeltzer PM, Boyett JM, Rorke LB, Allen JC, Geyer JR, Stanley P, Li H, Albright AL, McGuire-Cullen P, Finlay JL, Stevens KR Jr, Milstein JM, Packer RJ and Wisoff J: Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 88: 695-703, 1998.
24. Rojas-Marcos I, Calvet D, Janoray P and Delattre JY: Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin. Neurology 61: 1019-1020, 2003.
25. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, et al: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328: 1725-1731, 1993.
26. Grill J, Le Deley MC, Gambarelli D, Raquin MA, Couanet D, Pierre-Kahn A, Habrand JL, Doz F, Frappaz D, Gentet JC, Edan C, Chastagner P and Kalifa C: French Society of Pediatric Oncology. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 19: 1288-1296, 2001.
27. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jaaskelainen J and Ram Z: A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neurooncology 5: 79-88, 2003.
28. Giese A, Kucinski T, Knopp U, Goldbrunner R, Hamel W, Mchdorn HM, Tonn JC, Hilt D and Westphal M: Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma. J Neurooncol 66: 351-360, 2004.
29. Laws ER Jr, Morris AM and Maartens N: Gliadel for pituitary adenomas and craniopharyngiomas. Neurosurgery 53: 255-269, 2003.
30. Park MC, Weaver CE Jr, Donahue JE and Sampath P: Intracavitary chemotherapy (Gliadel) for recurrent esthesioneuroblastoma: case report and review of the literature. J Neurooncol 77: 47-51, 2006.
31. Limentani SA, Asher A, Heafner M, Kim JW and Fraser R: A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme. J Neurooncol 72: 241-244, 2005.
32. Gururangan S, Cokgor L, Rich JN, Edwards S, Affronti ML, Quinn JA, Herndon JE II, Provenzale JM, McLendon RE, Tourt-Uhlig S, Sampson JH, Stafford-Fox V, Zaknoen S, Early M, Friedman AH and Friedman HS: Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neurooncology 3: 246-250, 2001.
33. Weingart J, Grossman SA, Carson KA, Fisher JD, Delaney SM, Rosenblum ML, Olivi A, Judy K, Tatter SB and Dolan ME: Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial. J Clin Oncol 25: 399-404, 2007.